EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mesothelin CAR ‐engineered NK cells derived from human embryonic stem cells suppress the progression of human ovarian cancer in animals

Yanhong Liu, Min Zhang, Xiaoyan Shen, Chengxiang Xia, Fangxiao Hu, Dehao Huang, Qitong Weng, Qi Zhang, Lijuan Liu, Yanping Zhu, Lei Wang, Jie Hao iD und 3 weitere

Cell Proliferation · 2024

DOI: 10.1111/cpr.13727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, 2024. Verfasst von Yanhong Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Ac…. Hauptthemen laut MEDLINE: Mesothelin, Killer Cells, Natural, Ovarian Neoplasms, Human Embryonic Stem Cells. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CAR‐NK cell therapy does not require HLA matching and has minimal side effects. However, traditional methods of engineering CARs into human tissue‐derived NK cells exhibit heterogeneity, low transduction efficiency, and high manufacturing costs. Here, we provide a reliable approach for generating large‐scale and cryopreserved mesothelin (MSLN) CAR‐NK cells from human embryonic stem cells (hESCs) as an alternative cell source. We first constructed MSLN CAR‐expressing hESCs to reduce CAR engineering costs and subsequently differentiated these stem cells into MSLN CAR‐NK cells via an efficient organoid induction system. The MSLN CAR‐NK cells exhibit the typical expression patterns of activating receptors, inhibitory receptors, and effector molecules of NK cells. In the presence of tumour cells, the MSLN CAR‐NK cells show increased secretion of IFN‐γ and TNF‐α, as well as elevated CD107a expression level compared with induced NK cells. We cryopreserved the MSLN CAR‐NK cells in liquid nitrogen using a clinical‐grade freezing medium (CS10) for more than 6 months to mimic an off‐the‐shelf CAR‐NK cell product. The thawed MSLN CAR‐NK cells immediately recovered after 48–72‐h culture and effectively eliminated ovarian tumour cells, including human primary ovarian tumour cells from patients. The thawed MSLN CAR‐NK cells efficiently suppressed ovarian tumour development in vivo and prolonged the survival of tumour‐bearing mice. Our study provides insights into the clinical translation of hESC‐derived MSLN CAR‐NK cells as a promising off‐the‐shelf cell product.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MesothelinKiller Cells, NaturalOvarian NeoplasmsHuman Embryonic Stem CellsGPI-Linked ProteinsHumansFemaleAnimalsMiceReceptors, Chimeric AntigenCell Line, TumorCryopreservationImmunotherapy, AdoptiveCell DifferentiationXenograft Model Antitumor Assays

Substanzen

MesothelinMSLN protein, humanGPI-Linked ProteinsReceptors, Chimeric AntigenMsln protein, mouse

Autor:innen und Institutionen

  • Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
  • Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China.
  • Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
  • National Stem Cell Resource Center, Chinese Academy of Sciences, Beijing, China.
  • Lead contact.

ORCID-Profile: Jie Hao

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Liu, Y., Zhang, M., Shen, X., Xia, C., Hu, F., Huang, D., Weng, Q., Zhang, Q., Liu, L., Zhu, Y., Wang, L., Hao, J., Zhang, M., Wang, T., & Wang, J. (2024). Mesothelin CAR ‐engineered NK cells derived from human embryonic stem cells suppress the progression of human ovarian cancer in animals. Cell Proliferation. https://doi.org/10.1111/cpr.13727

Vancouver

Liu Y, Zhang M, Shen X, Xia C, Hu F, Huang D, et al. Mesothelin CAR ‐engineered NK cells derived from human embryonic stem cells suppress the progression of human ovarian cancer in animals. Cell Proliferation. 2024. doi:10.1111/cpr.13727

BibTeX
@article{Liu2024,
  author = {Liu, Yanhong and Zhang, Min and Shen, Xiaoyan and Xia, Chengxiang and Hu, Fangxiao and Huang, Dehao and Weng, Qitong and Zhang, Qi and Liu, Lijuan and Zhu, Yanping and Wang, Lei and Hao, Jie and Zhang, Mengyun and Wang, Tongjie and Wang, Jinyong},
  title = {Mesothelin CAR ‐engineered NK cells derived from human embryonic stem cells suppress the progression of human ovarian cancer in animals},
  journal = {Cell Proliferation},
  year = {2024},
  doi = {10.1111/cpr.13727}
}
Kostenlos starten →